Panés, Julian <br/><br/>
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.  [electronic resource] 

 -  Gut  06 2017 
 - 1049-1059 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3288 
<br/><br/><label>Standard No.: </label>10.1136/gutjnl-2016-312735  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>C-Reactive Protein--metabolism<br/>Crohn Disease--blood<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Maintenance Chemotherapy<br/>Male<br/>Middle Aged<br/>Piperidines--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Pyrroles--administration & dosage<br/>Remission Induction<br/>Severity of Illness Index